T: +1 512 394 3040
F: +1 512 394 3001
T: +1 213 808 5700
F: +1 213 808 5760

Related Events

Related Publications

Related News

Amy L. Rudd is a trial lawyer in the complex commercial litigation group. Her practice spans several practice areas, including general business litigation, class action defense, product liability and mass torts, and trademark and copyright matters. In 2016, she was recognized by The Legal 500 US for her product liability and mass tort defense practice in the areas of consumer products, pharmaceuticals and medical devices, and toxic tort.

Ms. Rudd has extensive courtroom experience, representing clients at both the trial court and appellate levels and serving as trial counsel in both state and federal courts. Ms. Rudd has also assisted clients in assessing, anticipating, and avoiding litigation risks associated with new and existing business strategies. Her clients have included Fortune 500 and international companies in the pharmaceutical, shipping, computer, entertainment, airline, manufacturing, and financial services industries.

In addition, Ms. Rudd maintains an active pro bono practice. She has been heavily involved in Texas voting rights litigation, most recently in connection with the fight against Texas’s photo voter ID law. On behalf of the Texas NAACP and the Mexican American Legislative Caucus, Ms. Rudd second-chaired the resulting two-week bench trial and helped secure a full plaintiffs’ victory. Ms. Rudd also helped draft the successful appellate briefing filed with the Fifth Circuit Court of Appeals, resulting in an opinion from the en banc panel affirming the trial court’s ruling that the Texas photo ID law has an unlawful discriminatory impact on minority voters in Texas. Based on her role in the appellate victory, Ms. Rudd was featured on CBS Radio News in 2016.

In her pro bono practice, Ms. Rudd also has represented a number of foreign domestic workers in litigation involving allegations of human trafficking and exploitation against her former employer, a high-ranking Kuwaiti diplomat. Ms. Rudd took the lead in preparing the successful briefing on appeal of the case to the U.S. Court of Appeals for the Second Circuit and appeared in the Second Circuit on her client’s behalf. The case was Swarna v. Al-Awadi, 622 F.3d 123 (2010). Based on this and the subsequent work of Ms. Rudd and her team, in 2016, Dechert was honored by The Financial Times as the Most Innovative Law Firm in North America in Social Responsibility.

Prior to joining Dechert, Ms. Rudd was an associate at a large international law firm, where she served as lead and co-lead counsel representing clients in litigation in both state and federal courts, as well as in arbitrations before various international tribunals.

Significant Representations

  • Representing DHL Express (USA), Inc. in trial and appellate matters pending in state and federal courts around the country, including in California, Michigan, New York, and Utah. In this capacity, Ms. Rudd has co-chaired numerous trials in state and federal court, including a two-week jury trial in 2016 in the United States District Court for the District of Utah and a one-month jury trial in the New York State Supreme Court. In the latter trial involving dozens of live witnesses, Dechert secured a full defense verdict on behalf of DHL. Ms. Rudd also was responsible for the meritorious briefing in an appeal to the Tenth Circuit Court of Appeals, securing the reversal of a US$25 million jury verdict against DHL, in Unishippers Global Logistics LLP v. DHL Express (USA), Inc., No. 11-4216, 2013 WL 2398761 (10th Cir. June 4, 2013).
  • Second-chairing the defense of a more than $200 million lawsuit filed in Delaware Chancery Court against a California-based private investment company arising from its purchase of a large nationwide chain of healthcare facilities. Dechert obtained a full defense verdict.
  • Representing a major pharmaceutical manufacturer in its defense of federal and state MDLs alleging that its testosterone product caused major adverse cardiovascular events. In that capacity, Ms. Rudd has played a lead role working up numerous bellwether cases for trial, requiring her to take depositions of plaintiffs and physicians across the country. The cases remain pending.
  • Acting as lead counsel for an individual defendant in securities fraud litigation pending in state court in Texas. The case is in the early stages of discovery.
  • Serving as lead class action defense counsel for a large internet company accused of violating the Telephone Consumer Protection Act. In the first class action filed in Texas federal court, Ms. Rudd obtained a full dismissal of the lawsuit. In the second class action filed in California federal court, Ms. Rudd obtained a very favorable settlement on behalf of the client on the eve of oral argument on class certification.
  • Acting as lead counsel on behalf of various Texas dental specialty organizations in litigation brought by several individual dentists and dental organizations challenging Texas’s regulation of dental specialty recognition as unconstitutional under the First Amendment.
  • Representing several California-based entertainment companies in trademark infringement litigation in California federal court and also advising those companies with respect to potential trademark infringement litigation in China, Malaysia, and Taiwan.
  • Playing a substantial role in the legal motion and advocacy strategy for AstraZeneca Pharmaceuticals LP in the Seroquel litigation – prevailing on Daubert and summary judgment motions that defeated the lead bellwether case in the federal MDL and state coordinated proceedings in Delaware and New Jersey, including Guinn v. AstraZeneca Pharms. LP, 598 F. Supp. 2d 1239 (M.D. Fla. 2009); Haller v. AstraZeneca Pharms. LP, 598 F. Supp. 2d 1271 (M.D. Fla. 2009); Scaife v. AstraZeneca LP, 2009 WL 1610575 (Del. Super. Ct. June 9, 2009); and Tate v. AstraZeneca Pharms. LP, No. MID-L-1608-07-MT (N.J. Super. Ct. Feb. 5, 2010). Ms. Rudd also prepared the meritorious briefing in an appeal of the lead MDL case for AstraZeneca Pharmaceuticals before the U.S. Court of Appeals for the Eleventh Circuit, Guinn v. AstraZeneca Pharms. LP, 602 F.3d 1245 (11th Cir. 2010), and was on the AstraZeneca trial team that secured a defense verdict in March 2010 from a New Jersey state court jury in Baker v. AstraZeneca Pharms. LP.
  • Representing a sovereign nation in an ICC arbitration and mediation with a leading foreign telecom operator concerning the operation and ownership of the nation’s mobile telephone network involving claims in excess of US$260 million.
  • Representing a major electric company in the successful chapter 11 reorganization of two of its primary subsidiaries, and also representing the company in various proceedings before the Federal Energy Regulatory Commission.
  • Defending a leading computer company in a patent infringement trial before the International Trade Commission and in related federal court proceedings.
  • Second-chairing a seven-day jury trial in a US$35 million breach of contract lawsuit filed against a Fortune 500 company; the lawsuit was favorably resolved before verdict.

Includes matters handled at Dechert or prior to joining the firm. 


The University of Texas at Austin, Bachelor of Journalism, 1997, with Honors
The University of Texas School of Law, J.D., 2000, with Honors

Bar Admissions/Qualifications